Salarius Pharmaceuticals, Inc.

Clinical-stage biopharma developing targeted protein therapies for cancer and viral diseases.

SLRX | NDAQ

Overview

Corporate Details

ISIN(s):: US79400X4043 (+1 more)
LEI:
Country:: United States of America
Address:: 2450 HOLCOMBE BLVD, 77021 HOUSTON
Website:: https://salariuspharma.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Salarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for patients with cancer and other diseases with high unmet medical needs. The company's technology aims to correct the dysregulated gene expression that drives disease progression. Its pipeline is built on two primary drug classes: targeted protein inhibitors (TPIs) and targeted protein degraders (TPDs). The lead TPI candidate, seclidemstat (SP-2577), is in Phase 1/2 clinical trials for solid and hematologic cancers like leukemias and lymphomas. The company's TPD candidate, SP-3164, is in IND-enabling studies. Following a merger with Decoy Therapeutics, Salarius is also advancing peptide therapeutics for cancer and respiratory viruses.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Salarius Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Salarius Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Salarius Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Haoxi Health Technology Ltd An online marketing solutions provider for the healthcare industry, focusing on video and news feed ads.	United States of America	HAO
Heidelberg Pharma AG Develops cancer therapies using its proprietary ATAC Antibody-Drug Conjugate technology.	Germany	HPHA
HighCo Data marketing firm offering digital solutions for brands & retailers to influence shopper behavior.	France	HCO
HireQuest, Inc. A franchisor of staffing solutions offering temporary labor and skilled placement to diverse industries.	United States of America	HQI
H.I.S. Co., Ltd. A major Japanese travel agency providing global tour packages, lodging, and transport.	Japan	9603
Hit Co., Ltd. Specialized OOH advertising firm providing digital & static billboards in high-visibility areas.	Japan	378A
HLB Therapeutics Co.,Ltd. Develops innovative drugs for rare eye diseases and brain tumors, with vaccine logistics.	South Korea	115450
HONYAKU Center Inc. Provides industrial translation and interpreting for patent, legal, and corporate clients.	Japan	2483
HS HYOSUNG Corporation A holding company for advanced materials, AI/data solutions, mobility, and global logistics.	South Korea	487570
Human Metabolome Technologies, Inc. A leader in metabolomics, providing CE-MS analysis to support R&D in biotech, pharma, and food.	Japan	6090